Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-121786
Filing Date
2025-05-16
Accepted
2025-05-16 17:05:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d874014ddefa14a.htm DEFA14A 21329
2 GRAPHIC g874014dsp1a.jpg GRAPHIC 122876
3 GRAPHIC g874014dsp1b.jpg GRAPHIC 14360
4 GRAPHIC g874014dsp1c.jpg GRAPHIC 3080
5 GRAPHIC g874014dsp1d.jpg GRAPHIC 2467
6 GRAPHIC g874014dsp1e.jpg GRAPHIC 1187
  Complete submission text file 0001193125-25-121786.txt   221332
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41583 | Film No.: 25960391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)